Table 1.
Comparative overview of advantages and disadvantages of different vehicle as artificial cells.
Vehicle | Advantages | Limitations | Reference |
---|---|---|---|
Liposomes | - Various sizes with either single or multiple lipid bilayers, - Diversity of lipid compositions - Simple fabrication process - Active clinical research |
- Potential complement activation and low cellular uptake - Insufficient drug loading and leakage - Premature drug release - Limited storage conditions |
[88, 89] |
Polymersomes | - More chemical stability lifetime than liposomes - Hydrophilic core and a hydrophobic bilayer allowing encapsulation of both hydrophilic and hydrophobic drugs - Functionality for targeted and stimuli-responsive (pH, redox, enzyme, ultrasound, magnetic field, light) drug delivery |
- Residual organic solvent - Incompetent control of the early drug release - Cumbersome fabrication steps, and toxicity concerns |
[90, 91] |
Dendrimersomes | - Modifiable branches of dendrimers - Controllable size and monodispersity - High penetration into cell membranes |
- High cost of productions - Improved quality control - Lack of clinical practice |
[92] |
Droplet-based artificial cells | - Simple and reproducible - Amenable to automation - Narrow size distribution - Large scale manufacturing - Small volumes |
- Manufacturing and microfluidic skills required - Limitations in generating nano-sized structures |
[93, 94] |